Neoantigen-based Personalized Cancer therapeutic Vaccines are one way to utilize the body’s immune system to fight cancer.
Neoantigens are non-autologous proteins which are specific to individuals and are a result of non-synonymous mutations in the tumor cell genome.
Bioinformatics-technological advancements, improved diagnosis, and a strong pipeline are some of the factors contributing to the advancement of Neoantigen based Personalized Cancer Therapeutic Vaccines Market.
Several key players such as Gradalis, OSE Immunotherapeutics, Immunitor, Gritstone Oncology, Genocea, Targovax, Hangzhou Neoantigen Therapeutics, Neon Therapeutics along with many others are robustly involved in fuelling Neoantigen-based Personalized Cancer therapeutic Vaccines market.
For more details visit: https://www.delveinsight.com/blog/neoantigen-based-personalized-cancer-therapeutic-vaccines-market/#utm_source=Blog%20promotion&utm_medium=Blog%20promotion&utm_campaign=Blog%20promotion